Attracting even 1% of the $200B annualized global biopharmaceutical investment may translate into $2B of FDI in a highly innovative sector of the economy. How are some governments and policymakers around the world disproportionally attracting and growing their share of international biopharmaceutical investment, while others are failing to attract it or keep it?
This panel of experts from government, industry and academia share their experiences and speak in very practical terms about what policies have proven effective in attracting and retaining this high-value add international investment while promoting a strong local research-based biopharmaceutical sector.

Session ID: 546633